AGA
BTAL icon

Arkos Global Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Arkos Global Advisors’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,629
Closed -$107K – 138
2026
Q1 		$107K Buy
+7,629
New +$107K 0.01% 156

Other funds holding BTAL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $675M AUM 17.92% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

Arkos Global Advisors's BTAL Position: Q2 2026 in Review

Arkos Global Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026, closing a stake of 7,629 shares — an estimated $107K sold.

Arkos Global Advisors first reported a position in BTAL in Q1 2026 and held it in 1 quarter. The position peaked at $107K in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Arkos Global Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2026 after selling out during the quarter.
  • Arkos Global Advisors sold 7,629 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $107K.
  • Arkos Global Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2026 and held it in 1 quarter.
  • Arkos Global Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $107K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Arkos Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.